THER ADV GASTROENTER 润色咨询

Therapeutic Advances in Gastroenterology

出版年份:2008 年文章数:770 投稿命中率: 开通期刊会员,数据随心看

出版周期:Bimonthly 自引率:1.3% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2167787, encodeId=664c216e787df, content=一审一个月,论文得到了审稿专家的认可和肯定,给出的修回意见也很中肯,二审一个月,秒接收!<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=037e6160919, createdName=ms5000001527012845, createdTime=Fri Nov 10 10:51:16 CST 2023, time=2023-11-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1105608, encodeId=abfa110560886, content=同一杂志社不同期刊如何转投(transfer)?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167000, encodeId=1873216e000af, content=审稿时间一个月,给了一个月时间大修。修改意见很详实不刁钻,看得出审稿人还是挺有水平的。赶了一个月实验后投出去。两个星期后就被接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf526407066, createdName=ms59932566, createdTime=Mon Nov 06 14:06:24 CST 2023, time=2023-11-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2166328, encodeId=0bf52166328b6, content=3月提交,4月中返修。评审给了比较多的意见,感觉是比较严苛的,但也很受用。大修6月提交,7月就收到了接收回复,赞!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54111233, createdTime=Thu Nov 02 17:36:17 CST 2023, time=2023-11-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2163260, encodeId=6db22163260a2, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:一般, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42aa6480365, createdName=ms5000001464638126, createdTime=Tue Oct 17 11:09:26 CST 2023, time=2023-10-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2098730, encodeId=c2982098e30e7, content=偏重的研究方向:肿瘤<br>经验分享:请问大家这个杂志不收基础研究吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936d8164413, createdName=ms8000000798079608, createdTime=Sat Nov 05 19:44:12 CST 2022, time=2022-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892149, encodeId=9fbd89214975, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:炎症性肠病<br>经验分享:审稿挺快的,第一次审稿一个多月给意见,两个审稿人,其中一个提了30多条意见,从写作,到分析等非常详细。给了个大修。另一个审稿人提的意见少一些。第二次审稿半个多月后,接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/08/1443c7a69fef248e40b457447f46c13e.jpg, createdBy=5b121939878, createdName=最后一根火柴, createdTime=Wed Oct 14 23:30:47 CST 2020, time=2020-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105607, encodeId=cd6f110560e70, content=所有作者在文章接收之后都会接收到邮件吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846915, encodeId=0fe4846915d1, content=胃肠肝病学里很好的一本期刊了,希望今年可以进中科院1区吧。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8ed5413972, createdName=ms9325659851846900, createdTime=Mon Sep 03 13:19:11 CST 2018, time=2018-09-03, status=1, ipAttribution=)]
    2023-11-10 ms5000001527012845 来自上海

    一审一个月,论文得到了审稿专家的认可和肯定,给出的修回意见也很中肯,二审一个月,秒接收!

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2167787, encodeId=664c216e787df, content=一审一个月,论文得到了审稿专家的认可和肯定,给出的修回意见也很中肯,二审一个月,秒接收!<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=037e6160919, createdName=ms5000001527012845, createdTime=Fri Nov 10 10:51:16 CST 2023, time=2023-11-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1105608, encodeId=abfa110560886, content=同一杂志社不同期刊如何转投(transfer)?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167000, encodeId=1873216e000af, content=审稿时间一个月,给了一个月时间大修。修改意见很详实不刁钻,看得出审稿人还是挺有水平的。赶了一个月实验后投出去。两个星期后就被接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf526407066, createdName=ms59932566, createdTime=Mon Nov 06 14:06:24 CST 2023, time=2023-11-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2166328, encodeId=0bf52166328b6, content=3月提交,4月中返修。评审给了比较多的意见,感觉是比较严苛的,但也很受用。大修6月提交,7月就收到了接收回复,赞!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54111233, createdTime=Thu Nov 02 17:36:17 CST 2023, time=2023-11-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2163260, encodeId=6db22163260a2, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:一般, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42aa6480365, createdName=ms5000001464638126, createdTime=Tue Oct 17 11:09:26 CST 2023, time=2023-10-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2098730, encodeId=c2982098e30e7, content=偏重的研究方向:肿瘤<br>经验分享:请问大家这个杂志不收基础研究吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936d8164413, createdName=ms8000000798079608, createdTime=Sat Nov 05 19:44:12 CST 2022, time=2022-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892149, encodeId=9fbd89214975, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:炎症性肠病<br>经验分享:审稿挺快的,第一次审稿一个多月给意见,两个审稿人,其中一个提了30多条意见,从写作,到分析等非常详细。给了个大修。另一个审稿人提的意见少一些。第二次审稿半个多月后,接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/08/1443c7a69fef248e40b457447f46c13e.jpg, createdBy=5b121939878, createdName=最后一根火柴, createdTime=Wed Oct 14 23:30:47 CST 2020, time=2020-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105607, encodeId=cd6f110560e70, content=所有作者在文章接收之后都会接收到邮件吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846915, encodeId=0fe4846915d1, content=胃肠肝病学里很好的一本期刊了,希望今年可以进中科院1区吧。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8ed5413972, createdName=ms9325659851846900, createdTime=Mon Sep 03 13:19:11 CST 2018, time=2018-09-03, status=1, ipAttribution=)]
    2021-12-27 学医的彭于晏

    同一杂志社不同期刊如何转投(transfer)?

    2

    展开2条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2167787, encodeId=664c216e787df, content=一审一个月,论文得到了审稿专家的认可和肯定,给出的修回意见也很中肯,二审一个月,秒接收!<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=037e6160919, createdName=ms5000001527012845, createdTime=Fri Nov 10 10:51:16 CST 2023, time=2023-11-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1105608, encodeId=abfa110560886, content=同一杂志社不同期刊如何转投(transfer)?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167000, encodeId=1873216e000af, content=审稿时间一个月,给了一个月时间大修。修改意见很详实不刁钻,看得出审稿人还是挺有水平的。赶了一个月实验后投出去。两个星期后就被接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf526407066, createdName=ms59932566, createdTime=Mon Nov 06 14:06:24 CST 2023, time=2023-11-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2166328, encodeId=0bf52166328b6, content=3月提交,4月中返修。评审给了比较多的意见,感觉是比较严苛的,但也很受用。大修6月提交,7月就收到了接收回复,赞!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54111233, createdTime=Thu Nov 02 17:36:17 CST 2023, time=2023-11-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2163260, encodeId=6db22163260a2, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:一般, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42aa6480365, createdName=ms5000001464638126, createdTime=Tue Oct 17 11:09:26 CST 2023, time=2023-10-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2098730, encodeId=c2982098e30e7, content=偏重的研究方向:肿瘤<br>经验分享:请问大家这个杂志不收基础研究吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936d8164413, createdName=ms8000000798079608, createdTime=Sat Nov 05 19:44:12 CST 2022, time=2022-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892149, encodeId=9fbd89214975, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:炎症性肠病<br>经验分享:审稿挺快的,第一次审稿一个多月给意见,两个审稿人,其中一个提了30多条意见,从写作,到分析等非常详细。给了个大修。另一个审稿人提的意见少一些。第二次审稿半个多月后,接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/08/1443c7a69fef248e40b457447f46c13e.jpg, createdBy=5b121939878, createdName=最后一根火柴, createdTime=Wed Oct 14 23:30:47 CST 2020, time=2020-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105607, encodeId=cd6f110560e70, content=所有作者在文章接收之后都会接收到邮件吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846915, encodeId=0fe4846915d1, content=胃肠肝病学里很好的一本期刊了,希望今年可以进中科院1区吧。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8ed5413972, createdName=ms9325659851846900, createdTime=Mon Sep 03 13:19:11 CST 2018, time=2018-09-03, status=1, ipAttribution=)]
    2023-11-06 ms59932566 来自上海

    审稿时间一个月,给了一个月时间大修。修改意见很详实不刁钻,看得出审稿人还是挺有水平的。赶了一个月实验后投出去。两个星期后就被接收。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2167787, encodeId=664c216e787df, content=一审一个月,论文得到了审稿专家的认可和肯定,给出的修回意见也很中肯,二审一个月,秒接收!<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=037e6160919, createdName=ms5000001527012845, createdTime=Fri Nov 10 10:51:16 CST 2023, time=2023-11-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1105608, encodeId=abfa110560886, content=同一杂志社不同期刊如何转投(transfer)?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167000, encodeId=1873216e000af, content=审稿时间一个月,给了一个月时间大修。修改意见很详实不刁钻,看得出审稿人还是挺有水平的。赶了一个月实验后投出去。两个星期后就被接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf526407066, createdName=ms59932566, createdTime=Mon Nov 06 14:06:24 CST 2023, time=2023-11-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2166328, encodeId=0bf52166328b6, content=3月提交,4月中返修。评审给了比较多的意见,感觉是比较严苛的,但也很受用。大修6月提交,7月就收到了接收回复,赞!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54111233, createdTime=Thu Nov 02 17:36:17 CST 2023, time=2023-11-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2163260, encodeId=6db22163260a2, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:一般, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42aa6480365, createdName=ms5000001464638126, createdTime=Tue Oct 17 11:09:26 CST 2023, time=2023-10-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2098730, encodeId=c2982098e30e7, content=偏重的研究方向:肿瘤<br>经验分享:请问大家这个杂志不收基础研究吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936d8164413, createdName=ms8000000798079608, createdTime=Sat Nov 05 19:44:12 CST 2022, time=2022-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892149, encodeId=9fbd89214975, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:炎症性肠病<br>经验分享:审稿挺快的,第一次审稿一个多月给意见,两个审稿人,其中一个提了30多条意见,从写作,到分析等非常详细。给了个大修。另一个审稿人提的意见少一些。第二次审稿半个多月后,接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/08/1443c7a69fef248e40b457447f46c13e.jpg, createdBy=5b121939878, createdName=最后一根火柴, createdTime=Wed Oct 14 23:30:47 CST 2020, time=2020-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105607, encodeId=cd6f110560e70, content=所有作者在文章接收之后都会接收到邮件吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846915, encodeId=0fe4846915d1, content=胃肠肝病学里很好的一本期刊了,希望今年可以进中科院1区吧。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8ed5413972, createdName=ms9325659851846900, createdTime=Mon Sep 03 13:19:11 CST 2018, time=2018-09-03, status=1, ipAttribution=)]
    2023-11-02 MS54111233 来自上海

    3月提交,4月中返修。评审给了比较多的意见,感觉是比较严苛的,但也很受用。大修6月提交,7月就收到了接收回复,赞!!!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2167787, encodeId=664c216e787df, content=一审一个月,论文得到了审稿专家的认可和肯定,给出的修回意见也很中肯,二审一个月,秒接收!<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=037e6160919, createdName=ms5000001527012845, createdTime=Fri Nov 10 10:51:16 CST 2023, time=2023-11-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1105608, encodeId=abfa110560886, content=同一杂志社不同期刊如何转投(transfer)?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167000, encodeId=1873216e000af, content=审稿时间一个月,给了一个月时间大修。修改意见很详实不刁钻,看得出审稿人还是挺有水平的。赶了一个月实验后投出去。两个星期后就被接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf526407066, createdName=ms59932566, createdTime=Mon Nov 06 14:06:24 CST 2023, time=2023-11-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2166328, encodeId=0bf52166328b6, content=3月提交,4月中返修。评审给了比较多的意见,感觉是比较严苛的,但也很受用。大修6月提交,7月就收到了接收回复,赞!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54111233, createdTime=Thu Nov 02 17:36:17 CST 2023, time=2023-11-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2163260, encodeId=6db22163260a2, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:一般, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42aa6480365, createdName=ms5000001464638126, createdTime=Tue Oct 17 11:09:26 CST 2023, time=2023-10-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2098730, encodeId=c2982098e30e7, content=偏重的研究方向:肿瘤<br>经验分享:请问大家这个杂志不收基础研究吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936d8164413, createdName=ms8000000798079608, createdTime=Sat Nov 05 19:44:12 CST 2022, time=2022-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892149, encodeId=9fbd89214975, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:炎症性肠病<br>经验分享:审稿挺快的,第一次审稿一个多月给意见,两个审稿人,其中一个提了30多条意见,从写作,到分析等非常详细。给了个大修。另一个审稿人提的意见少一些。第二次审稿半个多月后,接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/08/1443c7a69fef248e40b457447f46c13e.jpg, createdBy=5b121939878, createdName=最后一根火柴, createdTime=Wed Oct 14 23:30:47 CST 2020, time=2020-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105607, encodeId=cd6f110560e70, content=所有作者在文章接收之后都会接收到邮件吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846915, encodeId=0fe4846915d1, content=胃肠肝病学里很好的一本期刊了,希望今年可以进中科院1区吧。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8ed5413972, createdName=ms9325659851846900, createdTime=Mon Sep 03 13:19:11 CST 2018, time=2018-09-03, status=1, ipAttribution=)]
    2023-10-17 ms5000001464638126 来自广东省

    审稿速度:1.0 | 投稿命中率:50.0
    经验分享:一般

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2167787, encodeId=664c216e787df, content=一审一个月,论文得到了审稿专家的认可和肯定,给出的修回意见也很中肯,二审一个月,秒接收!<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=037e6160919, createdName=ms5000001527012845, createdTime=Fri Nov 10 10:51:16 CST 2023, time=2023-11-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1105608, encodeId=abfa110560886, content=同一杂志社不同期刊如何转投(transfer)?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167000, encodeId=1873216e000af, content=审稿时间一个月,给了一个月时间大修。修改意见很详实不刁钻,看得出审稿人还是挺有水平的。赶了一个月实验后投出去。两个星期后就被接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf526407066, createdName=ms59932566, createdTime=Mon Nov 06 14:06:24 CST 2023, time=2023-11-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2166328, encodeId=0bf52166328b6, content=3月提交,4月中返修。评审给了比较多的意见,感觉是比较严苛的,但也很受用。大修6月提交,7月就收到了接收回复,赞!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54111233, createdTime=Thu Nov 02 17:36:17 CST 2023, time=2023-11-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2163260, encodeId=6db22163260a2, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:一般, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42aa6480365, createdName=ms5000001464638126, createdTime=Tue Oct 17 11:09:26 CST 2023, time=2023-10-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2098730, encodeId=c2982098e30e7, content=偏重的研究方向:肿瘤<br>经验分享:请问大家这个杂志不收基础研究吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936d8164413, createdName=ms8000000798079608, createdTime=Sat Nov 05 19:44:12 CST 2022, time=2022-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892149, encodeId=9fbd89214975, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:炎症性肠病<br>经验分享:审稿挺快的,第一次审稿一个多月给意见,两个审稿人,其中一个提了30多条意见,从写作,到分析等非常详细。给了个大修。另一个审稿人提的意见少一些。第二次审稿半个多月后,接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/08/1443c7a69fef248e40b457447f46c13e.jpg, createdBy=5b121939878, createdName=最后一根火柴, createdTime=Wed Oct 14 23:30:47 CST 2020, time=2020-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105607, encodeId=cd6f110560e70, content=所有作者在文章接收之后都会接收到邮件吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846915, encodeId=0fe4846915d1, content=胃肠肝病学里很好的一本期刊了,希望今年可以进中科院1区吧。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8ed5413972, createdName=ms9325659851846900, createdTime=Mon Sep 03 13:19:11 CST 2018, time=2018-09-03, status=1, ipAttribution=)]
    2022-11-05 ms8000000798079608

    偏重的研究方向:肿瘤
    经验分享:请问大家这个杂志不收基础研究吗

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2167787, encodeId=664c216e787df, content=一审一个月,论文得到了审稿专家的认可和肯定,给出的修回意见也很中肯,二审一个月,秒接收!<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=037e6160919, createdName=ms5000001527012845, createdTime=Fri Nov 10 10:51:16 CST 2023, time=2023-11-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1105608, encodeId=abfa110560886, content=同一杂志社不同期刊如何转投(transfer)?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167000, encodeId=1873216e000af, content=审稿时间一个月,给了一个月时间大修。修改意见很详实不刁钻,看得出审稿人还是挺有水平的。赶了一个月实验后投出去。两个星期后就被接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf526407066, createdName=ms59932566, createdTime=Mon Nov 06 14:06:24 CST 2023, time=2023-11-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2166328, encodeId=0bf52166328b6, content=3月提交,4月中返修。评审给了比较多的意见,感觉是比较严苛的,但也很受用。大修6月提交,7月就收到了接收回复,赞!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54111233, createdTime=Thu Nov 02 17:36:17 CST 2023, time=2023-11-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2163260, encodeId=6db22163260a2, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:一般, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42aa6480365, createdName=ms5000001464638126, createdTime=Tue Oct 17 11:09:26 CST 2023, time=2023-10-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2098730, encodeId=c2982098e30e7, content=偏重的研究方向:肿瘤<br>经验分享:请问大家这个杂志不收基础研究吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936d8164413, createdName=ms8000000798079608, createdTime=Sat Nov 05 19:44:12 CST 2022, time=2022-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892149, encodeId=9fbd89214975, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:炎症性肠病<br>经验分享:审稿挺快的,第一次审稿一个多月给意见,两个审稿人,其中一个提了30多条意见,从写作,到分析等非常详细。给了个大修。另一个审稿人提的意见少一些。第二次审稿半个多月后,接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/08/1443c7a69fef248e40b457447f46c13e.jpg, createdBy=5b121939878, createdName=最后一根火柴, createdTime=Wed Oct 14 23:30:47 CST 2020, time=2020-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105607, encodeId=cd6f110560e70, content=所有作者在文章接收之后都会接收到邮件吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846915, encodeId=0fe4846915d1, content=胃肠肝病学里很好的一本期刊了,希望今年可以进中科院1区吧。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8ed5413972, createdName=ms9325659851846900, createdTime=Mon Sep 03 13:19:11 CST 2018, time=2018-09-03, status=1, ipAttribution=)]
    2020-10-14 最后一根火柴

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向:炎症性肠病
    经验分享:审稿挺快的,第一次审稿一个多月给意见,两个审稿人,其中一个提了30多条意见,从写作,到分析等非常详细。给了个大修。另一个审稿人提的意见少一些。第二次审稿半个多月后,接收了。

    5

    展开5条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2167787, encodeId=664c216e787df, content=一审一个月,论文得到了审稿专家的认可和肯定,给出的修回意见也很中肯,二审一个月,秒接收!<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=037e6160919, createdName=ms5000001527012845, createdTime=Fri Nov 10 10:51:16 CST 2023, time=2023-11-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1105608, encodeId=abfa110560886, content=同一杂志社不同期刊如何转投(transfer)?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167000, encodeId=1873216e000af, content=审稿时间一个月,给了一个月时间大修。修改意见很详实不刁钻,看得出审稿人还是挺有水平的。赶了一个月实验后投出去。两个星期后就被接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf526407066, createdName=ms59932566, createdTime=Mon Nov 06 14:06:24 CST 2023, time=2023-11-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2166328, encodeId=0bf52166328b6, content=3月提交,4月中返修。评审给了比较多的意见,感觉是比较严苛的,但也很受用。大修6月提交,7月就收到了接收回复,赞!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54111233, createdTime=Thu Nov 02 17:36:17 CST 2023, time=2023-11-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2163260, encodeId=6db22163260a2, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:一般, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42aa6480365, createdName=ms5000001464638126, createdTime=Tue Oct 17 11:09:26 CST 2023, time=2023-10-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2098730, encodeId=c2982098e30e7, content=偏重的研究方向:肿瘤<br>经验分享:请问大家这个杂志不收基础研究吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936d8164413, createdName=ms8000000798079608, createdTime=Sat Nov 05 19:44:12 CST 2022, time=2022-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892149, encodeId=9fbd89214975, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:炎症性肠病<br>经验分享:审稿挺快的,第一次审稿一个多月给意见,两个审稿人,其中一个提了30多条意见,从写作,到分析等非常详细。给了个大修。另一个审稿人提的意见少一些。第二次审稿半个多月后,接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/08/1443c7a69fef248e40b457447f46c13e.jpg, createdBy=5b121939878, createdName=最后一根火柴, createdTime=Wed Oct 14 23:30:47 CST 2020, time=2020-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105607, encodeId=cd6f110560e70, content=所有作者在文章接收之后都会接收到邮件吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846915, encodeId=0fe4846915d1, content=胃肠肝病学里很好的一本期刊了,希望今年可以进中科院1区吧。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8ed5413972, createdName=ms9325659851846900, createdTime=Mon Sep 03 13:19:11 CST 2018, time=2018-09-03, status=1, ipAttribution=)]
    2021-12-29 MS54455111222

    所有作者在文章接收之后都会接收到邮件吗?

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2167787, encodeId=664c216e787df, content=一审一个月,论文得到了审稿专家的认可和肯定,给出的修回意见也很中肯,二审一个月,秒接收!<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=037e6160919, createdName=ms5000001527012845, createdTime=Fri Nov 10 10:51:16 CST 2023, time=2023-11-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1105608, encodeId=abfa110560886, content=同一杂志社不同期刊如何转投(transfer)?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167000, encodeId=1873216e000af, content=审稿时间一个月,给了一个月时间大修。修改意见很详实不刁钻,看得出审稿人还是挺有水平的。赶了一个月实验后投出去。两个星期后就被接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf526407066, createdName=ms59932566, createdTime=Mon Nov 06 14:06:24 CST 2023, time=2023-11-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2166328, encodeId=0bf52166328b6, content=3月提交,4月中返修。评审给了比较多的意见,感觉是比较严苛的,但也很受用。大修6月提交,7月就收到了接收回复,赞!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54111233, createdTime=Thu Nov 02 17:36:17 CST 2023, time=2023-11-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2163260, encodeId=6db22163260a2, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:一般, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42aa6480365, createdName=ms5000001464638126, createdTime=Tue Oct 17 11:09:26 CST 2023, time=2023-10-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2098730, encodeId=c2982098e30e7, content=偏重的研究方向:肿瘤<br>经验分享:请问大家这个杂志不收基础研究吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936d8164413, createdName=ms8000000798079608, createdTime=Sat Nov 05 19:44:12 CST 2022, time=2022-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892149, encodeId=9fbd89214975, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:炎症性肠病<br>经验分享:审稿挺快的,第一次审稿一个多月给意见,两个审稿人,其中一个提了30多条意见,从写作,到分析等非常详细。给了个大修。另一个审稿人提的意见少一些。第二次审稿半个多月后,接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/08/1443c7a69fef248e40b457447f46c13e.jpg, createdBy=5b121939878, createdName=最后一根火柴, createdTime=Wed Oct 14 23:30:47 CST 2020, time=2020-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105607, encodeId=cd6f110560e70, content=所有作者在文章接收之后都会接收到邮件吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846915, encodeId=0fe4846915d1, content=胃肠肝病学里很好的一本期刊了,希望今年可以进中科院1区吧。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8ed5413972, createdName=ms9325659851846900, createdTime=Mon Sep 03 13:19:11 CST 2018, time=2018-09-03, status=1, ipAttribution=)]
    2018-09-03 ms9325659851846900

    胃肠肝病学里很好的一本期刊了,希望今年可以进中科院1区吧。

    0

共19条页码: 1/2页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分